CCP Approves CDC Investment in NCMCL Under Competition Act Review

Approves CDC’s Investment in NCMCL

The (CCP) has approved the proposed investment by Central Depository Company of Pakistan Limited (CDC) in Naymat Collateral Management Company Limited (NCMCL). This approval was granted following a Phase-I review under the Competition Act, 2010.

CDC submitted a pre-merger application to the CCP seeking approval for additional shareholding in NCMCL. The Commission’s competition assessment concluded that the transaction would not significantly alter competition dynamics as CDC and NCMCL operate in separate business segments.

Founded in 1993, CDC is one of Pakistan’s key capital market institutions providing electronic custody of securities and settlement facilitation services. Established in 2020, NCMCL operates as a collateral management company overseeing warehouses under the Electronic Warehouse Receipt framework.

The CCP’s decision underscores its commitment to facilitating investment while ensuring competition and consumer welfare are protected.